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Abstract
Background: Recent data suggest that 10–20% of injury patients will suffer for several months after the event from
diverse symptoms, generally referred to as post-concussion-like symptoms (PCLS), which will lead to a decline in quality
of life. A preliminary randomized control trial suggested that this condition may be induced by the stress experienced
during the event or emergency room (ER) stay and can be prevented in up to 75% of patients with a single, early, short
eye movement desensitization and reprocessing (EMDR) psychotherapeutic session delivered in the ER.
The protocol of the SOFTER 3 study was designed to compare the impact on 3-month PCLS of early EMDR intervention
and usual care in patients presenting at the ER. Secondary outcomes included 3-month post-traumatic stress disorder,
12-month PCLS, self-reported stress at the ER, self-assessed recovery expectation at discharge and 3 months, and self-
reported chronic pain at discharge and 3 months.
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Methods: This is a two-group, open-label, multicenter, comparative, randomized controlled trial with 3- and 12-month
phone follow-up for reports of persisting symptoms (PCLS and post-traumatic stress disorder). Those eligible for inclusion
were adults (≥18 years old) presenting at the ER departments of the University Hospital of Bordeaux and University
Hospital of Lyon, assessed as being at high risk of PCLS using a three-item scoring rule. The intervention groups were a
(1) EMDR Recent Traumatic Episode Protocol intervention performed by a trained psychologist during ER stay or (2) usual
care. The number of patients to be enrolled in each group was 223 to evidence a 15% decrease in PCLS prevalence in
the EMDR group.
Discussion: In 2012, the year of the last national survey in France, 10.6 million people attended the ER, some of whom
did so several times since 18 million visits were recorded in the same year. The SOFTER 3 study therefore addresses a
major public health challenge.
Trial registration: Clinical Trials. NCT03400813. Registered 17 January 2018 – retrospectively registered.
Keywords: Stress, Emergency department, Eye movement desensitization and reprocessing, Post-concussion-like
symptoms, Post-traumatic stress disorder, Clinical trial
Background
In 2012, when the latest national survey was conducted in
France, 10.6 million people reported having attended the
emergency room (ER), some of whom did so several times
since 18 million ER visits were recorded in the same year
[1]. In general, over 90% of those attending the ER will be
discharged within hours, without hospitalization [2].
Recent consistent observations [3–6] that 10–20% of in-
jury patients will suffer for several months after the event
from diverse symptoms, with a subsequent decline in
quality of life that can be significant and delay or prevent
the resumption of school or work activities, as well as
changing social and family relationships, are of major
public health consequences. Approximately 2 million
people each year in France are confronted by difficulties
of varying degrees whose cause is often unidentified and
unrelated to the traumatic event. This link is all the more
difficult to make as these symptoms appear to be
non-specific, and include headaches, concentration
disorders, memory problems, stress intolerance, personal-
ity change, and irritability. These symptoms have been
described for more than 50 years in the context of head
trauma, and were therefore referred to as post-concussion
syndrome (PCS). Surprisingly, the most recent results
show that these symptoms are not specific to brain injur-
ies and can occur in other patients presenting to the ER
[5, 7, 8], greatly expanding the size of the population con-
cerned. In a cross-sectional, observational study of 31,958
high school athletes, Iverson et al. [9] also found that 19%
of uninjured boys and 28% of uninjured girls reported
having a symptom burden resembling an ICD-10 diagno-
sis of PCS; thereafter, these symptoms were frequently
described as post-concussion-like symptoms (PCLS).
Recognizing that brain damage is not the main cause of
these symptoms, researchers have compared patients with
and without PCLS with two objectives, namely to predict
their occurrence and to understand why they occur. This
framework led to the major conclusion that psychological
vulnerability, on the one hand, and stress experienced
during and in the aftermath of the event, on the other, are
the two best predictors of these lasting symptoms. This
finding has been repeatedly observed in studies that assess
the factors associated with PCLS [9–15].
The study of post-traumatic stress disorder (PTSD) has
received renewed interest in view of the psychological pain
of soldiers from Western countries returning from
overseas following medical trauma, shedding light on this
major public health phenomenon also affecting patients
who have suffered an accident, physical assault, or an
acute medical condition and whose general health remains
precarious several months or years later. These studies
have led to a better characterization of PTSD, including
the individualization of four dimensional components,
namely re-experiencing, avoidance, hyperactivation of the
nervous system, and cognitive and emotional numbing
[16]. Symptoms of PCLS are very similar and even some-
times exactly the same as the last two dimensions of
PTSD (hyperactivation of the nervous system and cogni-
tive and emotional numbing). This led various authors to
hypothesize that PCLS and PTSD partly share the same
causal pathway, in which stress plays a key role. This
would be particularly relevant for prevention of PCLS, in
particular because, in contrast to PTSD studies, PCLS
studies include insufficient numbers and are of low quality
to identify credible modes of intervention [17].
Our research team has conducted two studies in the
past 10 years that enabled us to further our understanding
of PCLS and to look for prevention opportunities. In
2007, we conducted a cohort study of 2018 patients with
mild traumatic brain injuries and 1447 other injury
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patients recruited in the adult ER of Bordeaux University
Hospital (Pericles project) [8, 10]. Follow-up to
12 months provided an unprecedented database
allowing for in-depth comparisons of patient sub-
groups. It was this study that showed that PCS, des-
pite its name, was not specific to head trauma [8],
and highlighted the importance of stress and the
overlap between PCS and PTSD [8, 10]. The data ob-
tained allows us today to compare the performance of
risk assessment tools designed to select patients at
increased risk of PCS from variables measured in the
ER. This last point is of major importance in the
preparation of this protocol.
Following the Pericles project, we conducted a pilot
study to identify the factors explaining the persistence of
symptoms 3 months after an injury event. The key result
of this pilot study (manuscript submitted) was that the
stress level reported by patients at the end of their ER
stay was a powerful predictor of PCLS and PTSD, irre-
spective of the stress level reported on entering the ER.
This important result prompted us to consider testing
the feasibility and then the effectiveness of stress man-
agement interventions during an ER stay, in the hope of
improving the outcomes of traumatized patients.
Results from the literature and these two studies led
us to initiate a literature search for the best intervention
candidates that would have the potential to lower stress
levels during an ER stay.
One of the first ideas proposed for patients who experi-
ence a stressful event was to initiate a stress management
procedure before the consolidation of stressful memories.
This is partly why the practice of psychological debriefing,
which consists of debriefing sessions conducted 2–10 days
after the critical incident, has been widely disseminated.
However, several critical reviews [18] and a Cochrane re-
view [19] have concluded that this form of intervention
leads to an increased rate of PTSD.
More promisingly, early exposure therapy, which is based
on the extinction of fear through engagement with
traumatic memories and clues, appears to be an effective
treatment of PTSD [20, 21]. PTSD syndrome can be inter-
preted as a failure of recovery caused, in part, by failure of
the extinction of trauma [22]. This is supported by research
conducted on animals showing that early extinction has
the potential to alter the consolidation of memory of ori-
ginal fear [23–25]. Rothbaum et al. [18] were the first to
show the effectiveness of an extinction-type intervention
(prolonged exposure) beginning in the ER in the preven-
tion of PTSD in a sample of 137 patients randomized to
three groups. The intervention also included two other ses-
sions 1 and 2 weeks later. The same authors showed that
such short-term intervention could also lower PTSD risk
in patients with genes previously found to be associated
with stress response [26]. Trauma-focused cognitive
behavioral therapy delivered within weeks of a potentially
traumatic event for people showing signs of distress was
also effective in the treatment of acute stress and early
PTSD symptoms, and in the prevention of PTSD [27–31].
However, the psychotherapeutic intervention that has
thus far proven superior to all other methods is eye move-
ment desensitization and reprocessing (EMDR). Conceived
by Francine Shapiro [32], EMDR is an empirically validated
psychotherapeutic approach that can rapidly process dis-
turbing experiences adaptively together with the aid of eye
movements or other forms of bi-lateral stimulation. Several
meta-analyses and Cochrane reviews have shown that this
is one of the most effective treatments for PTSD [32–35].
Treatment may be started soon after the trauma, but most
often after a complaint from the patient who is already suf-
fering from PTSD symptoms. More recently, a study by
Tarquinio et al. [36] showed the effectiveness of an
EMDR-based intervention initiated in the first 48 h. The
target population of this study was workers who have
suffered professional violence (assaults, robberies, etc.).
A study conducted in Israel showed very promising re-
sults with a single-session, early modified EMDR session
provided in a general hospital inpatient and outpatient set-
ting to 86 patients with acute stress syndrome suffering
from intrusion distress following accidents and terrorist
bombing attacks [37]. Half of the patients reported imme-
diate fading of intrusive symptoms and general alleviation
of distress, 27% described partial alleviation of their symp-
toms and distress, while 23% reported no improvement. At
the 4- and 6-month follow-up, the immediate responders
in the terror victims group remained symptom free, while
the non-responders endorsed more risk factors for PTSD.
These results support other anecdotal reports on the rapid
effects of brief EMDR intervention on intrusive symptoms
in early uncomplicated post-traumatic cases.
Following the recognition of the failure of psycho-
logical debriefing, the issue of difficult access to pa-
tients with high levels of stress or dissociation was
raised. This was all the more critical as it was known
that dissociation at the time at which exposure ther-
apy starts was associated with a poorer response [18].
In response to this challenge and to the increasing
number of patients in need of care after manmade
catastrophes such as bomb attacks, modified EMDR
procedures and protocols adapted for early interven-
tion have been developed to help victims and can be
applied soon after trauma, including the emergency
response procedure (ERP) [38] and the recent trau-
matic episode protocol (R-TEP) [39, 40].
The ERP is a short procedure implemented accord-
ing to procedures designed and tested in emergency
contexts, including the ER [40, 41]. The individuals
who arrive at the ER show a wide range of disturb-
ance. The greatest benefit of the ERP intervention is
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expected for patients in a ‘highly agitated’ state (scor-
ing 7–10/10 on the Subjective Units of Disturbance
scale, where 0 = no disturbance and 10 = the highest
disturbance possible) to those who have moved into a
‘silent terror’ (scoring 10+/10 on the Subjective Units
of Disturbance scale).
The R-TEP is an early EMDR current trauma-focused
intervention that incorporates and extends the main
ideas of the original Recent Event Protocol guidelines
first described by Shapiro and Laub in 2008 [42].
The ICD-10 established a set of diagnostic criteria for
PCS. In order to meet these criteria, a patient must have
had a head injury “usually sufficiently severe to result in
loss of consciousness” followed by the development,
within 4 weeks, of at least three of the eight following
symptoms: headache, dizziness, fatigue, irritability, sleep
problems, concentration problems, memory problems,
and problems tolerating stress. There is relatively little
systematic research on the prevention and treatment of
PCS [43–46]. A systematic review published in 2010
[45] suggested that cognitive behavioral therapy may be
effective in the treatment of PCS. However, the authors
found no quality studies and call for more rigorous trials
of cognitive behavioral therapy for post-concussion
symptoms. Other strategies include information, educa-
tion and reassurance [47–49]. An emerging literature
points to the independent impact of expectations and
coping on chronic conditions following trauma, in par-
ticular for patients with whiplash and low back pain
[50–55]. Reassurance, as provided in the context of can-
cer [50], low back pain [51, 52], and mild head trauma
[47, 49], was found to help patients in their recovery
process. It is therefore possible that at least a subgroup
of patients who experienced a traumatic injury may
benefit from such intervention.
Available research data, both from our studies and that
available in the literature, led us to select the EMDR
R-TEP procedure. This choice was based on the follow-
ing considerations:
1) The absence of sufficient literature related to
preventive interventions for PCLS
2) The partial overlap between PCLS and PTSD
3) The results of our preliminary studies strongly
suggesting that stress plays a major role in PCLS
4) The consensus for the use of EMDR in early
prevention of PTSD
5) The growing evidence of a significant psychological
component to persistent complaints
6) The failure of early psychological debriefing to
prevent PTSD
We then conducted a new pilot study [53], intended to
examine the feasibility of stress management sessions
during the ER stay with candidate interventions as
selected by our literature search. To this end, we
conducted a randomized open-label, single-center study
to assess the feasibility of psychologist-led interventions
in the context of the ER and to compare the effect of
EMDR with reassurance and usual care. Conducted in
the ER of Bordeaux University Hospital, the study in-
cluded patients with a high risk of PCLS randomized
into three groups, as follows: (1) a 15-min reassurance
session, (2) a 60-min session of EMDR, and (3) usual
care. Main outcomes were the proportion of interven-
tions that could be carried out and the prevalence of
PCLS and PTSD 3 months after the ER visit.
A total of 130 patients with a high risk of PCLS
were randomized. No logistic problem or patient re-
fusal was observed. In the EMDR, reassurance and
control groups, the proportions of patients with PCLS
at 3 months were 18%, 37%, and 65% and those with
PTSD were 3%, 16%, and 19%, respectively. The rela-
tive risk for PCLS adjusted for the type of event (in-
jury, non-injury) for the comparison between EMDR
and control was 0.24 (95% CI 0.095–0.61). This first
randomized controlled trial therefore shows that a
short EMDR intervention is feasible and potentially
effective in the context of the ER. The study was reg-
istered at ClinicalTrials.gov (NCT03194386).
The present protocol aims to replicate the latter trial
in order to confirm or reject our hypothesis of a benefi-
cial impact of early R-TEP EMDR on PCLS and PTSD
in two different ERs. SPIRIT Checklist for this trial is
provided as an Additional file 1.
Potential benefit
The trial is designed to test the impact of early EMDR
intervention on PCLS and PTSD in patients presenting
to the ER. In 2012, the year of the last national survey in
France, 10.6 million people attended the ER, some of
whom several times, since 18 million visits were re-
corded that year. The SOFTER 3 study therefore ad-
dresses a major public health challenge.
Methods/design
The main objective in our two-site, open-label, ran-
domized controlled trial is to compare the impact on
3-month PCLS of early EMDR R-TEP intervention and
usual care in patients presenting to the ER. Secondary
objectives include the comparison between EMDR
R-TEP and control of 3-month PTSD, 12-month PCLS,
self-reported stress at ER discharge, self-assessed recov-
ery expectation at discharge and 3 months, and
self-reported pain at discharge and 3 months.
The outcomes are therefore defined as follows:
Primary outcome
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– 3-month PCLS as measured with the Rivermead
Post-Concussion Symptoms Questionnaire [54]
Secondary outcomes
– 12-month PCLS as measured with the Rivermead
Post-Concussion Symptoms Questionnaire
– 3-month PTSD as measured with PTSD Checklist-5
[55]
– Self-assessed recovery expectation at discharge and
3 months
– Self-reported chronic pain at 3 months
– Self-reported acute pain at discharge
– Psychotropic medicine use at 3 months as measured
by drug delivery data extracted from the Caisse
national d’assurance maladie des travailleurs salariés
(CNAM-TS) database, the French social insurance
system
Randomization and blinding
Patients will be allocated to one of the two arms with
block randomization by clinical center sites. Statistical
analysis will be performed blinded to arm content, re-
vealed only by the Data Safety Monitoring Board
(DSMB) report. It is not possible to blind the partici-
pants to their allocation due to the nature of the
intervention.
Inclusion criteria
All patients attending the adult ER of one of the study
sites following an event that led to an injury, or with a
new acute medical condition, will be assessed for inclu-
sion. The inclusion criteria are as follows:
 Age 18 and above
 Conscious, able to provide informed consent, able to
understand study procedures and to comply with
them for the entire length of the study; French
speaker
 Injured, whatever the cause of injury (the event
causing the injury must have occurred in the past
12 h) or experiencing a medical event associated
with an acute medical condition and presenting for
the first time to the ER for this reason
 Score resulting from the screening tool > 1: female:
+ 1, taking at least one anxiolytic treatment: + 1,
perceived health status prior to admission: excellent,
very good 0; good: + 1; poor: + 2; bad + 3
 Affiliated to the French insurance system
Exclusion criteria
Any candidates to whom any of the exclusion criteria
apply at baseline will be excluded from study participa-
tion. The exclusion criteria are as follows:
 Acute drug or alcohol use or dependence that, in
the opinion of the site investigator, would interfere
with adherence to study requirements
 Inability or unwillingness of individual or legal
guardian/representative to give written informed
consent
 Inability or unwillingness to be contacted for 3- and
12-month follow-up interviews
Study enrollment procedures and randomization
Study protocol and time of collection of outcomes are
presented in Figs. 1 and 2. Participants will be re-
cruited among patients presenting to the ERs of the
University Hospital of Bordeaux (Groupe Hospitalier
Pellegrin) and Lyon (Groupement Hospitalier Edouard
Herriot) and assessed with a high risk of PCLS. The
identification and recruitment of potential study par-
ticipants will be carried out by emergency personnel
under the supervision of the project manager as soon
as the patient’s condition permits and in all cases
after the initial clinical evaluation conducted in the
framework of the usual care. First oral consent will
then be sought for participation in the assessment
stage, which consists in selecting patients with a high
risk of PCLS.
A set of three items will be recorded for each injured
patient, including sex (+ 1 for female), perceived health
status prior to admission (excellent, very good: 0; good:
+ 1 poor: + 2; bad: + 3), current use of anxiolytics/antide-
pressants (+ 1 if yes).
To be enrolled in the study, the patient will need to
score above a pre-defined threshold of 2 on the scoring
procedure based on the three items and designed to se-
lect patients at risk for PCLS. The score has been devel-
oped using data from the Pericles study and validated on
data of the SOFTER Pilot 1 and 2 studies.
Patients fulfilling inclusion criteria and assessed as
at risk for PCLS will be presented with the objective
and procedures and invited to sign an informed con-
sent form. A screening log will be filled in to describe
reasons for ineligibility and for non-participation of
eligible candidates.
The randomization procedure for assigning a partici-
pant to an intervention group will then be performed
and the results will be recorded in the Shared Study
Monitoring System. Electronic block randomization will
be stratified according to study center. Block sizes will
be randomly modified and kept secret.
Intervention
Patients in the EMDR group will receive a 1-hour psy-
chotherapeutic intervention, utilizing the R-TEP [40].
This protocol is specially designed for victims of recent
traumatic events, and incorporates and extends the early
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EMDR intervention protocols [32] into an integrative
and comprehensive intervention considering the frag-
mented, unconsolidated nature of recent traumatic
memories and the need for safety and containment. Fol-
lowing the eight phases of the standard EMDR protocol,
it introduces four new procedural concepts (Traumatic
Episode, Episode Narrative, “Google Search/ Scan” for
identifying disturbing fragments and Current Trauma
Focused processing strategies). These sessions will be
carried out by trained psychologists.
Patients in the treatment-as-usual group will be med-
ically and psychologically attended to by ER staff with
no intervention of the study psychologist.
Sample size
The study sample size is calculated using PCLS rates ex-
pected at 3 months after an ER admission in a patient
population assessed to be at high risk of PCLS.
Our pilot study showed that, using the criteria de-
scribed above, the incidence of PCLS among patients se-
lected and enrolled in the study will be of approximately
47%. Our aim is to design the present study to be able
to evidence a 15% decrease in PCLS prevalence in the
EMDR group. Assuming an alpha risk of 5% and a
power of 80%, the required sample size will be 169 pa-
tients in each group. We further assumed 20% loss to
follow-up and 5% missing data for the main variables.
Fig. 1 Overview study diagram
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Thus, we plan to include 223 patients in each group
(112 per center in each group).
A study therapist will be available from 10 am to 6 pm,
5 days a week. Considering EMDR session duration and
emergency care, patients will be assessed for eligibility
from 8 am to 6 pm. Data from our ER registry and experi-
ence from our pilot study show that, during this period,
approximately 50 patients will be assessed for eligibility.
The screening tool used in this study will select approxi-
mately 10% of patients admitted to the ER. We also esti-
mate that 10% of eligible patients will be missed in the ER
and assume a 5% refusal rate. Consequently, we can ex-
pect approximately four inclusions per day, corresponding
to an inclusion period of 3 months.
Adherence assessment
Adherence to the study regimen will be defined as the
extent to which participants comply with study interven-
tion requirements. The SOFTER Pilot study 2 showed
that over 95% adherence can be expected in the EMDR
group. A log of intervention sessions will be kept for
each participant and will include duration, completeness,
and patient satisfaction. This log will be regularly
reviewed by the Steering Committee and used as part of
the decision to continue or discontinue the study.
Interim analyses and stopping rules
No interim analysis of efficacy is planned. The study can
be stopped by the DSMB for safety reasons or because of
poor study performance (losses to follow-up > 25%), poor
quality control, slow accrual (recruitment rate < 75% than
expected), serious adverse events considered to be caused
by the intervention, or increased frequency of adverse
events. Such findings are presented to the DSMB for re-
view of the events to determine whether there are statis-
tical as well as clinical concerns. The statistician reports
their findings to a closed session of the DSMB and these
are used to determine what steps will be taken.
Data analyses
Descriptive and inferential statistical methods will be
used to analyze the outcomes and other study data. Con-
founding variables will include cause of admission (in-
jury versus medical), age group, and sex. The analyses
will be conducted as intent-to-treat for primary endpoint
and per-protocol for secondary analyses. Randomization
codes will only be revealed at the end of the analysis.
Primary analyses will be conducted using a Fisher exact
test. A stratified analysis will be carried out considering
study center and PCLS risk score. For other variables,
Wilcoxon test will assess differences for continuous vari-
ables and Fisher exact test for categorical variables.
Differences between patients who completed the study
and those who were lost to follow-up will be assessed
for all variables.
Dissemination
The results of the trial will be published regardless of
the direction of effect. Communications will be pre-
sented at specialized conferences and reports will be
submitted to peer-reviewed medical journals.
Quality control
A clinical research associate mandated by the sponsor will
regularly visit each study center, when the research is set
up, once or several times during the course of research,
according to the rhythm of the inclusions and at the end
of the research. During these visits, and in accordance
with the monitoring plan, the following will be reviewed:
Informed consent
– Respect of the research protocol and procedures
defined in it
Fig. 2 Schedule of enrolment, interventions, and assessments
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– Quality of the data collected in the report file:
completeness, accuracy, missing data, consistency of
data with source documents (medical records,
appointment books, original laboratory results, etc.)
All visits will be subject to a written monitoring
report.
Confidentiality of data
In accordance with the statutory provisions in place (the
French Public Health Code), persons having direct ac-
cess to source data will take every precaution required
to ensure the confidentiality of information relating to
investigational medicinal products, studies, and partici-
pants, notably concerning their identity, as well as the
results obtained. These persons, like the investigators
themselves, are subject to professional confidentiality.
During the clinical study or at its conclusion, data
regarding participants that is collected and sent to the
sponsor by the investigators (or all other specialists in-
volved) will be anonymized. At no point will the names
of participants or their addresses appear unencrypted.
Only the first letters of the first name and full name of
included patients will be recorded, followed by a specific
research number indicating the rank of inclusion and
the origin of the investigator site.
The sponsor will ensure that each study participant
has given their consent for access to their personal data,
which is strictly required for study quality control.
Data and Safety Monitoring Board (DSMB)
The DSMB is an independent group of experts that ad-
vises the study investigators. The members of the DSMB
serve in an individual capacity and provide their expert-
ise and recommendations. The primary responsibilities
of the DSMB are to (1) periodically review and evaluate
the accumulated study data for participant safety, study
conduct and progress, and, when appropriate, efficacy,
and (2) make recommendations concerning the continu-
ation, modification, or termination of the trial. The
DSMB considers study-specific data as well as relevant
background knowledge about the patient population
under study.
The DSMB is responsible for defining its deliberative
processes, including event triggers that would call for an
unscheduled review, stopping guidelines, unmasking, and
voting procedures prior to initiating any data review.
The study DSMB consists of three independent experts,
inclduing one expert in the clinical aspects of the stressed/
injured patient population; one biostatistician with expertise
in current clinical trial conduct and methodology; and one
expert in psychotherapeutic EMDR interventions.
The DSMB has been appointed prior to study initiation.
Premature withdrawal from the study and withdrawal of
consent
The participant has the right to withdraw from the re-
search at any time. If participants decide to withdraw from
all components of the study, they are no longer followed
up in the protocol. Premature withdrawal from the re-
search strategy must be notified promptly to the Steering
Committee. The reasons for and the date of withdrawal
must be documented. The withdrawal of consent is a deci-
sion by a participant to reconsider their decision to partici-
pate in the research and to assert their right to withdraw
consent at any time during follow-up, without resulting in
any prejudice thereby and without having to justify it.
When a participant withdraws consent for participation in
the research, data already collected for this patient will be
kept for analysis.
Protocol deviations
Deviations can affect all aspects of a research protocol
such as inclusion, monitoring, measurement of end-
points, and treatment process. All deviations must be
documented by the investigator and discussed by the
Steering Committee and Data Management Center.
Even in the event of deviation from the protocol, par-
ticipants must be monitored until the date planned in
the protocol.
Archiving study documents and study data
The protocol and any changes to the protocol, report
files (copies), source files of participants who gave con-
sent, and all other documents and correspondence re-
lated to the research will be archived in accordance with
good clinical practices for a period of 15 years following
the end of the research. The original informed consent
forms of participants will be archived for a period of
30 years following the end of the research.
Ethical approval
The sponsor and the investigator(s) undertake the re-
sponsibility to ensure that the research is conducted in
compliance with Law no. 2012–300 on research involv-
ing human participants of 5 March 2012, in accordance
with Good Clinical Practices (I.C.H. version 4 of 9 No-
vember 2016 and Decision of 24 November 2006), and
the Declaration of Helsinki.
The research will be conducted in accordance with the
present protocol. Except in emergency situations requiring
specific medical procedures, the investigator undertakes the
responsibility to comply with the protocol in all respects,
particularly with regard to the collection of consent, and
the reporting and monitoring of serious adverse events.
This research project has received positive endorsement
from the French CPP (Comité de protection de Personnes
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Ouest II - Angers). N° RCB = 2017-A01462–51 – N°CPP
= 2017/36.
The University Hospital of Bordeaux, the sponsor of
this research, has taken out a civil liability insurance
contract with Gerling-Biomedicinsure in accordance
with the provisions of the public health code.
The data recorded in the course of this research shall
be subject to computer processing on behalf of INSERM
U1219 Bordeaux Population Health Research Center in
compliance with Law No. 78–17 of 6 January 1978 relat-
ing to data processing, files and freedoms, as amended
by Law 2004–801 of 6 August 2004.
This research project falls within the framework of the
“Reference Methodology” (MR-001) in application of the
provisions of article 54, paragraph 5 of the amended law
of 6 January 1978 relating to information, files and free-
doms. This change was approved by the decision of 5
January 2006, updated on 21 July 2016. The INSERM
U1219 Bordeaux Population Health Research Center has
signed a commitment to comply with this “Reference
Methodology”.
A specific request for clearance will be submitted to the
Commission Nationale Informatique et Liberté (CNIL) in
order to obtain the authorization to use the national social
security ID to retrieve medication data at 3 and 12 months.
Discussion
The trial is designed to test the impact of early EMDR
intervention on PCLS and PTSD in patients presenting to
the ER. In 2012, the year when the last national survey in
France was undertaken, 10.6 million people attended the
ER, some of whom several times, since 18 million visits
were recorded that year. The SOFTER 3 study therefore
addresses a major public health challenge.
We already described the feasibility of short EMDR
sessions in the ED during the SOFTER 2 study [53],
which also found a superiority of EMDR versus reassur-
ance versus control. We need to confirm these results in
a larger and more diverse population.
Trial status
The present publication refers to the 4.0 version of the
SOFTER 3 protocol dates on 01/02/2018. Recruitment
began on January 15, 2018, and is expected to be com-
pleted by the June 15, 2018.
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